The simplified reference tissue model: model assumption violations and their impact on binding potential
- PMID: 25425078
- PMCID: PMC4426748
- DOI: 10.1038/jcbfm.2014.202
The simplified reference tissue model: model assumption violations and their impact on binding potential
Abstract
Reference tissue models have gained significant traction over the last two decades as the methods of choice for the quantification of brain positron emission tomography data because they balance quantitative accuracy with less invasive procedures. The principal advantage is the elimination of the need to perform arterial cannulation of the subject to measure blood and metabolite concentrations for input function generation. In particular, the simplified reference tissue model (SRTM) has been widely adopted as it uses a simplified model configuration with only three parameters that typically produces good fits to the kinetic data and a stable parameter estimation process. However, the model's simplicity and its ability to generate good fits to the data, even when the model assumptions are not met, can lead to misplaced confidence in binding potential (BPND) estimates. Computer simulation were used to study the bias introduced in BPND estimates as a consequence of violating each of the four core SRTM model assumptions. Violation of each model assumption led to bias in BPND (both over and underestimation). Careful assessment of the bias in SRTM BPND should be performed for new tracers and applications so that an appropriate decision about its applicability can be made.
Figures
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4426748/bin/jcbfm2014202f1.gif)
![Figure 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4426748/bin/jcbfm2014202f2.gif)
![Figure 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4426748/bin/jcbfm2014202f3.gif)
![Figure 4](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4426748/bin/jcbfm2014202f4.gif)
![Figure 5](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4426748/bin/jcbfm2014202f5.gif)
![Figure 6](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4426748/bin/jcbfm2014202f6.gif)
![Figure 7](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4426748/bin/jcbfm2014202f7.gif)
Similar articles
-
Quantification of 18F-JNJ-42259152, a novel phosphodiesterase 10A PET tracer: kinetic modeling and test-retest study in human brain.J Nucl Med. 2013 Aug;54(8):1285-93. doi: 10.2967/jnumed.112.118679. Epub 2013 Jul 10. J Nucl Med. 2013. PMID: 23843566 Clinical Trial.
-
Evaluation of semi-quantitative method for quantification of dopamine transporter in human PET study with ¹⁸F-FE-PE2I.Ann Nucl Med. 2015 Oct;29(8):697-708. doi: 10.1007/s12149-015-0993-3. Epub 2015 Jul 2. Ann Nucl Med. 2015. PMID: 26134215
-
Quantitative analysis of dopamine transporters in human brain using [11C]PE2I and positron emission tomography: evaluation of reference tissue models.Ann Nucl Med. 2010 May;24(4):249-60. doi: 10.1007/s12149-010-0364-z. Epub 2010 Apr 3. Ann Nucl Med. 2010. PMID: 20364374
-
Kinetic modeling in positron emission tomography.Q J Nucl Med. 2002 Mar;46(1):70-85. Q J Nucl Med. 2002. PMID: 12072847 Review.
-
Quantification in PET.Radiol Clin North Am. 2004 Nov;42(6):1055-62, viii. doi: 10.1016/j.rcl.2004.08.010. Radiol Clin North Am. 2004. PMID: 15488557 Review.
Cited by
-
PET Imaging of the Serotonin 1A Receptor in Major Depressive Disorder: Hierarchical Multivariate Analysis of [11C]WAY100635 Overcomes Outcome Measure Discrepancies.bioRxiv [Preprint]. 2024 Mar 12:2024.03.12.584569. doi: 10.1101/2024.03.12.584569. bioRxiv. 2024. PMID: 38559101 Free PMC article. Preprint.
-
Nonlinear Mixed-Effects Modeling Approach for Simplified Reference Tissue Model.IEEE Trans Biomed Eng. 2024 Apr;71(4):1191-1196. doi: 10.1109/TBME.2023.3330693. Epub 2024 Mar 20. IEEE Trans Biomed Eng. 2024. PMID: 37930902
-
Is serotonin transporter brain binding associated with the cortisol awakening response? An independent non-replication.PLoS One. 2023 Aug 31;18(8):e0290663. doi: 10.1371/journal.pone.0290663. eCollection 2023. PLoS One. 2023. PMID: 37651457 Free PMC article.
-
Striatal dopamine transporter and receptor availability correlate with relative cerebral blood flow measured with [11C]PE2I, [18F]FE-PE2I and [11C]raclopride PET in healthy individuals.J Cereb Blood Flow Metab. 2023 Jul;43(7):1206-1215. doi: 10.1177/0271678X231160881. Epub 2023 Mar 13. J Cereb Blood Flow Metab. 2023. PMID: 36912083 Free PMC article.
-
Decreased synaptic vesicle glycoprotein 2A binding in a rodent model of familial Alzheimer's disease detected by [18F]SDM-16.Front Neurol. 2023 Feb 8;14:1045644. doi: 10.3389/fneur.2023.1045644. eCollection 2023. Front Neurol. 2023. PMID: 36846134 Free PMC article.
References
-
- Banati RB, Goerres GW, Myers R, Gunn RN, Turkheimer FE, Kreutzberg GW, et al. [11C](R)-PK11195 positron emission tomography imaging of activated microglia in vivo in Rasmussen's encephalitis. Neurology. 1999;53:2199–2203. - PubMed
-
- Gunn RN, Lammertsma AA, Cunningham VJ. Quantitative Functional Brain Imaging with Positron Emission Tomography. Academic Press: San Diego; 1998. Parametric imaging of ligand-receptor interactions using a reference tissue model and cluster analysis; pp. 401–406.
-
- Innis RB, Cunningham VJ, Delforge J, Fujita M, Gjedde A, Gunn RN, et al. Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab. 2007;27:1533–1539. - PubMed
-
- Mintun MA, Raichle ME, Kilbourn MR, Wooten GF, Welch MJ. A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography. Ann Neurol. 1984;15:217–227. - PubMed
-
- Gunn RN, Gunn SR, Cunningham VJ. Positron emission tomography compartmental models. J Cereb Blood Flow Metab. 2001;21:635–652. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous